Company Overview

We are a science-based health care company improving patient care through neurotechnology

Medical Devices

• Founded in 1996 as MIT/Harvard Medical School spinoff
• Based near Boston, MA
• Public since 2004. Listed on Nasdaq as "NURO"

Focused on Point-of-Care Nerve Testing

• Created concept and market
• Market leader - 10 years plus, 5 million nerves tested, 1.5 million patients
• Premier R&D capability in the space, proprietary technology, Intellectual Property

Two Aspects to the Business

• Emerging business in diabetes care
• Established business in neurodiagnostics
• Orthopedics (hand surgery), primarily diagnosis of carpal tunnel syndrome
• General purpose nerve testing within primary care